Japanese Encephalitis
📧 Sign up to get email alerts when something new happens for Japanese Encephalitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
An ongoing recruitment update for a One Health study evaluating the risk of community spread of multiple endemic infectious diseases. The st…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults [Phase 1, Phase 2]
A Phase 1/2 clinical trial update indicates ongoing evaluation of the safety, reactogenicity, and immunogenicity of SK Bioscience's Japanese…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus
This clinical trial update describes a protocol in Cambodian children to diagnose and surveil acute meningitis/encephalitis with a focus on …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization
Completed clinical trial assessing safety observations of the Japanese Encephalitis vaccine when given with a primary immunization. The spon…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) [Phase 4]
Phase 4 trial evaluating immunogenicity when a Japanese encephalitis vaccine is co-administered with a Measles-Mumps-Rubella vaccine; the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis [Phase 4]
Phase 4 clinical trial evaluating immunogenicity, safety, and antibody persistence of different immunization strategies against Japanese enc…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Flavivirus Cross-priming Potential of IMOJEV [NA]
Clinical trial update indicates a completed study evaluating the flavivirus cross-priming potential of IMOJEV. Results have been posted in 2…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas [Phase 4]
Phase 4 clinical trial updating monitoring of Japanese encephalitis antibody levels in healthy populations and evaluation of immunization st…
-
EMA approval · 2023-05-25EMA Authorised: Ixiaro (Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)) — Valneva Austria GmbH
EMA authorises Ixiaro (Japanese encephalitis vaccine) for immunization against Japanese encephalitis.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province [Phase 4]
Phase 4 trial update evaluating seroprevalence of neutralizing antibodies against Japanese Encephalitis virus in 6-year-old children across …
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Purified Inactivated Japanese Encephalitis Vaccine [Phase 3]
Phase 3 clinical trial update for a purified inactivated Japanese Encephalitis vaccine targeting Japanese Encephalitis Virus Disease.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose [Phase 4]
Phase 4 trial assessing long-term immunogenicity, antibody response, and safety after a booster dose of JE vaccine in Japanese encephalitis …
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Japanese Encephalitis Vaccine when administered with the MMR vaccine.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine [Phase 4]
Phase 4 trial assessing boosterability of live attenuated Japanese Encephalitis vaccine in children previously given inactivated JE vaccine;…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine [Phase 3]
Phase 3 trial evaluating safety and efficacy of Japanese Encephalitis vaccine when co-administered with measles vaccine has completed and re…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals. [Phase 4]
Phase 4 trial update on immune responses after booster immunisation with IXIARO in elderly vs young individuals.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 [Phase 4]
Phase 4 trial updating human T cell responses to live attenuated Japanese Encephalitis vaccine SA14-14-2; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age [Phase 4]
This Phase 4 trial update reports results on coadministering a live attenuated Japanese encephalitis vaccine with a measles vaccine in 9-mon…
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine [Phase 4]
Phase 4 trial assessing lot-to-lot consistency for the Japanese Encephalitis live attenuated SA 14-14-2 vaccine; results posted after comple…
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age [Phase 2]
Phase 2 trial update assessing safety of Vero cell-derived inactivated JE vaccine JECEVAX in children aged 9-24 months.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam [Phase 3]
A Phase 3 clinical trial evaluating safety and immunogenicity of a Vero cell–derived Japanese Encephalitis vaccine in children 9-24 months i…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine [Phase 4]
Phase 4 clinical trial assessing humoral and cellular immune responses to a Japanese Encephalitis vaccine in elderly participants, with the …
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea [Phase 3]
Phase 3 trial update evaluating a booster dose of IMOJEV one year after primary immunization in healthy children in South Korea.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers [Phase 3]
Long-term follow-up results from a Phase 3 trial evaluating a single-dose Japanese Encephalitis chimeric virus vaccine (JE-CV) in toddlers, …
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV [Phase 3]
Phase 3 trial update for JE-CV in children previously immunized with JE-CV; study completed and results posted in 2017.